- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Strides Pharma Science Limited — Updates, 31-07-2026: Press Release
31-07-2026 | 12:39 pm
31-07-2026 | 12:39 pm
Strides Pharma's Q1FY27 revenue rose 13% YoY to ₹1,265.4 Cr, led by 17% Ex-US growth. EBITDA increased 5.4% to ₹229.8 Cr, absorbing ₹13.1 Cr geopolitical costs. The company unlocked ₹100 Cr from Pivot Path divestment and reduced net debt by ₹11.9 Cr.
No comments yet. Be the first to comment!